Madam Speaker, perhaps it would be better if you did undertake that.
We do not have a time frame, because we do not have the answers to how complicated this is, how the provinces are going to react, and how the different agencies that already have a pharmacare program are going to adapt. There is a lot of private industry involved. Private industry pays, provinces pay, the federal government pays, patients pay, there are a lot of different payers now. We are talking about having one payer in the end.
Our committee report will hopefully develop a model to work with. I do not have a time frame.